The Global Fund

What The Global Fund does

The Global Fund to Fight AIDS, Tuberculosis and Malaria is an international financing institution headquartered in Geneva, Switzerland, founded in 2002. It mobilizes donor capital through periodic replenishment conferences and deploys it as grants to more than 100 countries to combat HIV/AIDS, tuberculosis, and malaria, while strengthening underlying health systems. The organization is governed by a multi-stakeholder Board and operates through a partnership model in which governments, civil society, the private sector, and affected communities co-design and co-implement programs via Principal Recipients that include national agencies, NGOs, and multilateral bodies such as WHO, UNICEF, UNDP, and PEPFAR.

Its core operational outputs are grant allocations of up to US$4 billion annually, pooled procurement and distribution of health products (antiretrovirals, insecticide-treated bed nets, TB medicines, diagnostic kits, and increasingly advanced therapeutics such as Gilead's lenacapavir for HIV PrEP), and capacity-building in disease surveillance, laboratory networks, and community health workforces. The organization invests roughly US$150 million annually in digital surveillance infrastructure and has upgraded 186 labs and trained 70,000+ community health workers across 34 countries as of 2024. Supporting technical assets include the Data Explorer and Data Service platforms providing open programmatic and financial data, and event-based surveillance, wastewater monitoring, and digital disease reporting tools deployed across implementing countries.

The Global Fund does not generate revenue from product sales; it raises funds through sovereign donor replenishments (UK, Germany, Sweden, US via PEPFAR), private philanthropy (Gates Foundation, GSK, ViiV Healthcare), corporate campaigns (Apple/(RED), with cumulative contributions exceeding US$270 million since 2006), and increasingly through co-financing arrangements with World Bank and Gavi (US$2 billion) and a proposed blended finance instrument projected to add up to US$1 billion annually by 2033. Its current Eighth Replenishment cycle (2026-2028) is underway following a documented funding crisis that triggered $1.5 billion in approved grant allocation cuts, alongside new program launches in lenacapavir rollout, rapid TB testing across 13 countries, and regional partnerships with Africa CDC and Asian Development Bank.

Name

The Global Fund

Legal name

The Global Fund to Fight AIDS, Tuberculosis and Malaria

Website

https://theglobalfund.org

Company type

Private

Founded year

2002

Operating status

Operating

Headcount range

501–1,000 employees

Short description

The Global Fund to Fight AIDS, Tuberculosis and Malaria is a Geneva-based multilateral financing institution that mobilizes and deploys donor capital as grants across 100+ countries to combat HIV/AIDS, tuberculosis, and malaria and to strengthen health systems.

Ownership category

akta.pro rank

Product category

Global Health Financing

NAICS

Grantmaking Foundations (813211), Grantmaking and Giving Services (81321), Voluntary Health Organizations (813212)

SIC

Federal & Federally-Sponsored Credit Agencies (6111), International Affairs (9721)

akta.pro primary industry

Global Health Financing Mechanisms (HLAJAKAC)

akta.pro secondary industries

Grantmaking & Philanthropic Funds (Institutional Donors) (BPADAOAB), Trust Funds & Multi-Donor Pooled Funds (BPADAOAE), Global Health Financing Mechanisms & Pooled Funds (HLAJAOAC), Public Health Financing, Budgeting & Grants Management (HLAJAMAC)

Keywords

• Global health financing
• HIV/AIDS programs
• Tuberculosis treatment
• Malaria prevention
• Health systems strengthening

Headquarters

HQ city

Geneva

HQ country

Switzerland

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Operations, Supply Chain, Personnel, Infrastructure, Others

Revenue model

1. Government Donor Replenishments: The Global Fund mobilizes resources through periodic replenishment conferences where donor governments commit funding for multi-year cycles (e.g., Eighth Replenishment). Major donors include Sweden, Germany, UK, and others.
2. Private Sector Philanthropy and Corporate Partnerships: Apple partnered with (RED) for a campaign donating $5 per qualifying Apple Pay purchase up to $3 million to the Global Fund. Corporate donors provide both financial contributions and in-kind support.
3. Blended Finance and Concessional Loans: A proposed hybrid model combining grants for the poorest countries with concessional loans for middle-income countries, projected to generate up to $1 billion annually in new financing by 2033.
4. Co-Financing Partnerships with Multilateral Institutions: Partnerships with World Bank, Gavi, and the Global Financing Facility involving co-financing agreements such as $2 billion with Gavi and The Global Fund plus up to $410 million from philanthropic partners.

Go-to-market motion2 records

Distribution channels3 records

Marketing channels8 records

Core offering

The Global Fund is an international financing institution that mobilizes and disburses grants to fight AIDS, tuberculosis, and malaria. It invests up to US$4 billion annually across more than 100 countries, channeling donor funds to governments, NGOs, and civil society organizations that implement HIV treatment, TB diagnosis and care, malaria prevention (including distribution of insecticide-treated nets), and broader health system strengthening programs.

Product overview

The Global Fund operates as a financing organization rather than a traditional product company. Its core 'product' is a grant funding mechanism that invests up to US$4 billion annually to defeat AIDS, TB, and malaria. Supporting offerings include the Data Explorer and Data Service tools for accessing investment and impact data, a Sourcing & Management platform for health product procurement, and regular Results Reports documenting outcomes. The organization unites global partners to find health solutions and take them to scale worldwide.

Differentiator

Problem solved

Functional benefit

Products and services

• Global Fund Grants Program

Quantifiable outcome

• 70 million lives saved through the Global Fund partnership
• +8 more outcomes

Named customers14 records

Segments5 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

15 partnerships are on record, tiered core and minor.

• World Bank GroupcoreStrategic or Co-development PartnerThe World Bank Group partnered with the Global Fund through $2 billion co-financing agreements and up to $410 million from the Global Financing Facility and Health System Transformation and Resilience Fund. The UHC Knowledge Hub was launched in Tokyo as a joint initiative.
• Gavi, the Vaccine AlliancecoreStrategic or Co-development PartnerGavi and the Global Fund entered into $2 billion co-financing agreements to support health programs in low- and middle-income countries.
• Ministry of Foreign Affairs of South KoreaminorGTM or Marketing PartnerSouth Korea's Ministry of Foreign Affairs co-hosts the annual Korea-Global Fund Procurement Forum with the Global Fund to help Korean bio-pharmaceutical and medical device companies access the Global Fund's procurement market.
• PEPFAR (U.S. President's Emergency Plan for AIDS Relief)coreStrategic or Co-development PartnerPEPFAR collaborates with the Global Fund on HIV prevention programs, including the expanded access to lenacapavir reaching up to 3 million people by 2028. Both organizations coordinate distribution infrastructure for HIV prevention drugs.
• UNICEFcoreImplementation/ SI/ Consulting PartnerUNICEF partners with the Global Fund on health product distribution, including malaria bed net campaigns such as the distribution of 16 million bed nets in Sudan in partnership with Sudan's Federal Ministry of Health.
• Gilead SciencescoreStrategic or Co-development PartnerGilead Sciences provides lenacapavir (its twice-yearly injectable HIV prevention drug) at no profit through PEPFAR and The Global Fund, with voluntary licensing agreements with six generic manufacturers for large-scale rollout expected in 2027.
• Clinton Health Access Initiative (CHAI)coreImplementation/ SI/ Consulting PartnerCHAI collects data on HIV services across sub-Saharan Africa and Asia, providing evidence on program outcomes and funding crisis impacts in partnership with the Global Fund.
• Africa CDCcoreStrategic or Co-development PartnerThe Global Fund and Africa CDC joined forces in 2026 to advance stronger, self-reliant health systems across Africa, intensifying collaboration with regional partners.
• Asian Development Bank (ADB)coreStrategic or Co-development PartnerADB and the Global Fund entered a US$2 million co-financing agreement to support the Philippines in advancing universal health care and expanding access to health services.
• AppleminorGTM or Marketing PartnerApple partnered with (RED) on a donation campaign supporting the Global Fund through Apple Pay transactions, with a cap of $3 million. Apple and (RED) have contributed over $270 million since 2006.
• (RED)minorGTM or Marketing Partner(RED) partners with Apple and the Global Fund on fundraising campaigns, including a limited-time campaign donating $5 per qualifying Apple Pay purchase up to $3 million during December 2025.
• Amref Health AfricacoreImplementation/ SI/ Consulting PartnerAmref Health Africa supports over 11,000 community health workers to fight TB and malaria in Kenya, in partnership with the Global Fund.
• UnitaidcoreStrategic or Co-development PartnerUnitaid co-invests with the Global Fund in new health products, including the New Nets Project (US$33 million each from 2018-2022) for new insecticide-treated nets and the Expert Review Panel for Diagnostics.
• CO 100% LIFE (Ukraine)coreImplementation/ SI/ Consulting PartnerA local HIV community network in Ukraine that organizes courier delivery of antiretrovirals and other medicines to homes during COVID-19, supported by Global Fund grants.
• ROOTS Africa (Zimbabwe)minorImplementation/ SI/ Consulting PartnerLed by Beatrice Savadye, ROOTS Africa provides door-to-door care in Zimbabwe including food parcels, travel authorizations, and antiretroviral treatments during COVID-19 lockdowns.

Scale indicators18 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Gavi, the Vaccine Alliance: Gavi is the most directly comparable multilateral financing mechanism, pooling donor funds and channeling them to low-income countries for immunization programs. It shares the replenishment model, Geneva-area base, co-financing partnerships with The Global Fund and the World Bank, and identical stakeholder governance (governments, civil society, private sector, foundations).
• Unitaid: Unitaid is a Geneva-based multilateral financing mechanism that co-invests with The Global Fund on innovative health products (e.g., the $33M-per-year New Nets Project). It is a direct peer in pooled-fund grantmaking for global health product access, though smaller in scale and focused on upstream innovation rather than at-scale deployment.
• PEPFAR (U.S. President's Emergency Plan for AIDS Relief): PEPFAR is the single largest bilateral HIV/AIDS financing mechanism and a co-funder of lenacapavir rollout alongside The Global Fund. It is comparable as a pooled fund targeting the same disease vertical in overlapping countries, with similar supply chain and treatment-on-therapy scale metrics.
• Bill & Melinda Gates Foundation: The Gates Foundation is the largest private philanthropic funder of global health, matching GSK and ViiV contributions and co-investing with The Global Fund on HIV/TB/malaria. Comparable as a pooled funder operating across the same disease verticals, though structured as a foundation rather than a multilateral replenishment vehicle.
• Clinton Health Access Initiative (CHAI): CHAI is a core implementation partner of The Global Fund, providing data and programmatic support across sub-Saharan Africa and Asia. Comparable as a pooled funder/implementer operating in HIV/TB/malaria service delivery, though smaller and operating more through technical assistance than direct grants.

Broad incumbents

• WHO (World Health Organization): WHO is a core technical and normative partner of The Global Fund and a much larger incumbent in global health governance. It is comparable in mandate (HIV, TB, malaria) but operates as the standard-setting, surveillance-coordinating UN agency rather than a financing mechanism, making it a broader incumbent with overlapping rather than competing scope.
• World Bank Group: The World Bank is a co-financing partner ($2B co-financing agreements) and a much broader multilateral development institution. It is comparable in operating scale and pooled-fund mechanisms for health in low-income countries, but its mandate extends well beyond health into infrastructure, education, and broader development finance.
• UNICEF: UNICEF is a core implementation partner (e.g., 16M bed net campaign in Sudan) and a comparable UN-affiliated organization with global health supply chain operations. It is a broader incumbent that serves overlapping beneficiaries (mothers, children) but covers a much wider mandate including education and child protection.

Emerging players

• Africa CDC: Africa CDC is a regional pooled-fund and coordination entity that signed a joint partnership with The Global Fund in May 2026 to strengthen self-reliant health systems. Comparable as a pooled health-financing/coordination mechanism, though geographically scoped to Africa and earlier-stage in financial scale.
• Global Financing Facility (GFF): The GFF is a World Bank-hosted pooled fund for women's, children's, and adolescents' health that channels up to $410M through the Health System Transformation and Resilience Fund with The Global Fund. Comparable as a pooled financing mechanism in overlapping low-income country footprints, though focused on RMNCH rather than HIV/TB/malaria specifically.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key highlights7 records

Customer concentration

• Xx.com/globalfund
• Facebookfacebook.com/theglobalfund
• LinkedInlinkedin.com/company/the-global-fund

Revenue estimate

Valuation estimate

Number of profiles

Profiles8 records

Funding overview

Funding rounds2 records

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about The Global Fund